ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Letter To The Editor: Humor Story On Dands

October 29, 1999

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010

NCI Summarizes AIDS Virus Developments

May 4, 1984

Salick Raises Nearly $50 Million, Proceeding With FCC Development

June 6, 1986

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007

NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research

May 14, 1993